Brief: Echo Lake Capital Offers To Acquire Quince Therapeutics, Inc
March 21 (Reuters) - Quince Therapeutics Inc QNCX.O :
* ECHO LAKE CAPITAL OFFERS TO ACQUIRE QUINCE THERAPEUTICS,
INC
* ECHO LAKE CAPITAL - SUBMITS PROPOSAL TO ACQUIRE ALL
OUTSTANDING
COMMON STOCK OF QUINCE THERAPEUTICS, WE DO NOT OWN FOR $1.60 PER
SHARE IN CASH
* ECHO LAKE CAPITAL - PROPOSAL IS NOT CONTINGENT ON OUTSIDE
FINANCING
* ECHO LAKE CAPITAL - BELIEVE QUINCE'S STOCK IS SEVERELY
UNDERVALUED
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges